Biopharma Services and ADA Medical Launch Full Research Services Platform
TORONTO--(BUSINESS WIRE)--Biopharma Services Inc. is pleased to announce that in collaboration with its sister company, ADA Medical Ltd., it can now offer a complete range of contract research services, from early pre-clinical drug development through to Phase I - IV clinical trials.
“ADA Medical’s pre-clinical drug development research services and late stage Phases IIb – IV medical research are a natural fit with Biopharma Services Inc. early stage Phases I - IIa”
“ADA Medical’s pre-clinical drug development research services and late stage Phases IIb – IV medical research are a natural fit with Biopharma Services Inc. early stage Phases I - IIa” commented Renzo DiCarlo, CEO of Biopharma Services Inc. and ADA Medical Ltd.
ADA Medical’s existing project management skills coupled with Biopharma’s pharmacodynamics, pharmacokinetics, biostatistics, data management, regulatory and quality assurance capabilities bring the needed management and quality oversight to create the discipline needed for drug research and clinical trials.
About ADA Medical Ltd.
ADA Medical Ltd. is a Research Partnership Group consisting of a group of research professionals dedicated to the successful implementation and completion of clinical research projects for the pharmaceutical, biotechnology and medical device industries.
We specialize in trial management and support for hospital based as well as outpatient Phase II through Phase IV clinical trials. Our sites are all located in Canada and each participates in multiple clinical trial projects in multiple therapeutic areas.
About BioPharma Services Inc. BioPharma Services Inc. is a physician-owned, physician-run, FDA-inspected, UK MHRA-inspected, and Health Canada-inspected Canadian Contract Research Organization (CRO) which specializes in the conduct of Phase I/IIa clinical trials and bioanalysis for innovative pharmaceutical, biotech and medical device companies from US, Canada, Australia and Europe. The company currently has a modern 174-bed clinical facility and a co-located bioanalytical laboratory in Toronto, Canada. The company is privately held, and it is headquartered in Toronto, Canada.
For additional information regarding this release, please contact M. Daniel Beaulieu at email@example.com.